Medtech Insights

The Asia Pacific dialysis access treatment device market will continue to experience modest growth through 2032 after recovering from the impact of COVID-19. The market will be primarily driven by…

The Asia Pacific dialysis access treatment device market will continue to experience modest growth through 2032 after recovering from the impact of COVID-19. The market will be primarily driven…

The Asia Pacific GI endoscopy device market was negatively impacted by the COVID-19 pandemic. Following recovery, the market will grow moderately throughout the forecast period, mainly due to…

Although the global COVID-19 pandemic negatively impacted the Asia Pacific structural heart closure device market in 2020, strong prepandemic growth trends in the PFO and LAA segments helped to…

The Asia Pacific ENT device market saw a severe short-term impact from the COVID-19 pandemic in 2020 as many ENT procedures were delayed or canceled. Although the market rebounded in 2021 and…

Although the global COVID-19 pandemic negatively impacted the Asia Pacific EP mapping and ablation device market in 2020, the market has shown strong recovery and will resume prepandemic growth…

The Asia Pacific GI endoscopy device market was negatively impacted by the COVID-19 pandemic. Following recovery, the market will grow moderately throughout the forecast period, mainly due…

The Asia Pacific biosurgical agent market was negatively impacted by the COVID-19 pandemic. However, the overall market for biosurgical agent will exhibit modest growth over the forecast period…

The Asia Pacific heart valve device market will continue to experience robust growth after recovering from the impact of COVID-19. The market will be primarily driven by rapid adoption of THV …

The Asia Pacific interventional oncology device market will see strong growth through 2032 driven by a large and rapidly expanding patient population, increasing popularity of minimally invasive…

The Asia Pacific large-joint reconstructive implant market was limited by the COVID-19 pandemic given that many hip and knee implant procedures are considered elective; however, the market…

The Asia Pacific large-joint reconstructive implant market was limited by the COVID-19 pandemic given that many hip and knee implant procedures are considered elective; however, the market…